![ECOG-ACRIN Cancer Research Group study EA9171 is enrolling patients for a clinical trial on Chronic Myeloid leukemia](https://oncodaily.com/pub/uploads/2024/06/IMG_0320-1280x669.jpeg)
Photo from ECOG-ACRIN Cancer Research Group/X
Jun 26, 2024, 05:07
ECOG-ACRIN Cancer Research Group study EA9171 is enrolling patients for a clinical trial on Chronic Myeloid leukemia
ECOG-ACRIN Cancer Research Group shared a post on X:
“Dr. Amer Zeidan of Smilow Cancer Hospital and Yale Cancer Center is leading clinical study EA9171, testing if adding a new drug to the usual treatment for chronic myelogenous leukemia could help patients. Learn more here.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023